Key result
The provided text is a journal masthead and contains no clinical study data.
Why the study?
How do the Improve and Geneva clinical risk assessment models compare in predicting symptomatic VTE or VTE-related death in medical inpatients?
Population
1,478 medical inpatients from eight Swiss hospitals
Comparison
Improve clinical risk assessment model (RAM) vs Geneva clinical risk assessment model (RAM)
Design
Cohort
Follow-up
90 days
Authors
Loading...
No usable data in source; leaves open all questions on thrombosis outcomes in cohorts.
How do the Improve and Geneva clinical risk assessment models compare in predicting symptomatic VTE or VTE-related death in medical inpatients?
Both the Improve and Geneva RAMs demonstrate comparably good discrimination for predicting hospital-acquired VTE in medical inpatients, though the Geneva RAM may offer higher sensitivity.
Blondon et al. (2018) studied this question. The provided text is a journal masthead and contains no clinical study data.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: